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ABSTRACT Histamine is a neurotransmitter in the central
nervous system and an important modulator of gastric acid
secretion, vasomotor control, inflammation, and allergic reac-
tions. In biological systems the formation of histamine from its
precursor histidine is catalyzed by the enzyme L-histidine
decarboxylase (HDC; L-histidine carboxy-lyase, EC 4.1.1.22).
We have cloned HDC-encoding cDNA from a fetal rat liver
cDNA library (phage A gtll) and have deduced the amino acid
sequence from the nucleotide sequence. The clone was proven
to be HDC cDNA by expression of active recombinant enzyme
in COS cells and by chromosomal mapping. The cDNA encodes
a protein ofMr 73,450 (655 amino acid residues). The discrep-
ancy between this molecular weight and the size of the purifiled
fetal liver protein subunits [Taguchi, Y., Watanabe, T.,
Kubota, H., Hayashi, H. & Wada, H. (1984) J. Biol. Chem.
259, 5214-5221] (M, = 54,000) suggests that HDC may be
posttranslationally processed. The 469 amino acid residues
from the amino-terminal portion of the protein share 50%
identity with rat and Drosophila L-dopa decarboxylases and
much less homology with other characterized amino acid
decarboxylases.
The biogenic amine histamine is a neurotransmitter in the
central nervous system and an important physiological mod-
ulator of gastric acid secretion, airway smooth-muscle tone,
vasomotor control, inflammation, and allergic reactions (1-
3). The formation of histamine from its precursor histidine is
catalyzed by the enzyme L-histidine decarboxylase (HDC;
L-histidine carboxy-lyase, EC 4.1.1.22). In rodents the en-
zyme is primarily localized in the brain (hypothalamic neu-
rons and projections to other brain regions) (4), the glandular
regions of the stomach (5), mast cells (6), and fetal liver (7).
HDC has been purified from rat stomach (5) and fetal liver (7)
and was shown to be a dimer consisting ofMr 54,000 subunits.
Like other mammalian amino acid decarboxylases, the en-
zyme utilizes pyridoxal phosphate as a coenzyme. Although
no primary amino acid sequence of mammalian or other
eukaryotic HDC is known, immunological studies indicated
that rodent HDC is closely related to L-dopa decarboxylase
(DDC) (8). In this manuscript we present the amino acid
sequence of rat HDC as deduced from the fetal liver cDNA11
and demonstrate its close homology to DDC, but not to other
characterized amino acid decarboxylases.
EXPERIMENTAL PROCEDURES
Preparation and Screening of cDNA Library. Poly(A)+
RNA from fetal liver (16 days after conception) was prepared
by guanidine thiocyanate extraction (9) and transcribed with
avian myeloblastosis virus reverse transcriptase. The second
strand was synthesized with RNase H and Escherichia coli
DNA polymerase I (10). After treatment with T4 DNA
polymerase to flush the ends, EcoRI linkers were applied by
ligation and cleaved with EcoRI. Gel filtration (Sepharose
CL-4B)-purified cDNA was ligated with dephosphorylated
EcoRI-cleaved phage A gt11 DNA, and the recombinants
were packaged in vitro (11). The unampliflied library was
screened on E. coli Y1088, with [32P]DNA as previously
described (12). Positive recombinants were plaque-purified,
and the DNA inserts were isolated by electroelution.
Transient Expression in Monkey Kidney Cells. The DNA
inserts from isolates HDC-18 and HDC-21 were cloned into
the expression vector pCMV5, a modified pCMV plasmid
(13) containing an EcoRI cloning site (the modified plasmid
was from David Russel and Matthew Lorence, University of
Texas Southwestern Medical Center, Dallas). This plasmid
vector contains the cytomegalovirus (CMV) promoter-
enhancer of the immediate early gene, the poly(A)+ addition-
transcription terminator region of the human growth hor-
mone gene, the simian virus 40 origin of replication, and a
polylinker region for the insertion of cDNAs (13). Recombi-
nants with the correct orientation for expression were iden-
tified by restriction endonuclease analysis, and the plasmid
DNA (pCMVHDC-18 and pCMVHDC-21) was purified by
CsCl/ethidium bromide centrifugation. For transfection,
subconfluent COS 7 cells (106 cells per 100-mm dish) were
transfected with 5 ug of pCMV DNA per dish by the
DEAE-dextran method (14). After 48 hr, the cells were
suspended in Ca2+/Mg2+-free phosphate-buffered saline and
lysed by three cycles of freeze (-70°)/thaw (370); the lysate
was assayed for protein and HDC and DDC enzymatic
activities. Conditions for the HDC assay were as described
(15), with 0.25 mM [3H]histidine as substrate. The formation
of [3H]histamine was determined by thin-layer chromatogra-
phy (16).
Chromosomal Localization. The production and character-
ization of the Chinese hamster-mouse somatic cell hybrids
has been described (17). NFS/N mice were obtained from the
Small Animal Section, National Institutes of Health. Mus
musculus musculus mice were originally trapped in Skive,
Denmark, and breeding pairs were provided by M. Potter
(National Cancer Institute) from his colony at Hazelton
Laboratories, Rockville, MD. NFS/N females were mated
with M. m. musculus males, and the F1 females were then
mated with M. m. musculus males. DNA extracted from the
livers of the backcross progeny was typed by Southern blot
Abbreviations: HDC, histidine decarboxylase; DDC, dopa decar-
boxylase; GAD, glutamic acid decarboxylase; PLP, pyridoxal phos-
phate; RFLP, restriction fragment length polymorphism; ABP, art-
drogen-binding protein; CMV, cytomegalovirus.
1The sequence reported in this paper has been deposited in the
GenBank data base (accession no. M29591).
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hybridization for restriction fragment length polymorphisms trophoresed on 0.4% agarose gels, and transferred to nylon
(RFLPs) of the hemolytic complement locus (Hc), the /32- membranes (Hybond N, Amersham); the membranes were
microglobulin locus (B2m), and the parotid secretory protein hybridized with [32P]cDNA probes for Hc, B2m, Psp, and
locus (Psp) by using probes provided by G. Barsh (University HDC-2.3 (Fig. 1 legend).
of California at San Francisco), B. Tack (Scripps Institute), Other Analytical Procedures. Restriction endonuclease di-
and D. Margulies (National Institutes of Health), respec- gestions of DNA and fractionation by agarose gel electro-
tively. DNAs were digested with restriction enzymes, elec- phoresis were done by standard techniques (ref. 18, pp. 98




GluMetValAspTyrI leCysGLnTyrLeuSerThrValArgGluArgGLnValThrProAsnValLysProGLyTyrLeuArgAlaGflIn leProSerSerALaProGtuGLuProAsp- - 55
AGCTGGGATAGCATCTTTGGGGACATTGAGCAAATCATCATGCCTGGGGTGGTTCACTGGCAGAGCCCCCACATGCACGCCTACTATCCGGCTCTCACCTCTTGGCCATCCCTGCTAGGA-- 360







GACGACAACTTCTCACTCCGAGGAGAAGCTCTCCAGAGGCCATCGAGGAAGACAGCAACAGGGCTTGGTGCCTGTGTT TGTCTGTGCACCTTAGGGACCACTGGAGTCTGTGCAT TT - - 840
AspAspAsnPheSerLeuArgGtyGtuAtaLeuGtnLysAtal LeGluGluAspLysGlnGlnGlyLeuValProValPheValCysAlaThrLeuGlyThrThrGlyValCysAlaPhe- - 255
T
GACAAGCTGTCAGAGCTGGGGCCCATCTGTGCCAGGGAGGGACTGTGGCTCCACGTCGATGCTGCTTATGCAGGAACAGCCTTTCTGlGCCCTGAGCTCCGGGGCTTCCTGAAGGGCATT-- 960
AspLysLeuSerGluLeuGLyProl leCysALaArgGLuGLyLeuTrpLeuHisValAspAlaAlaTyrAlaGlyThrAlaPheLeuArgProGLuLetArgGLyPheLeuLysGyyI le-- 295
GAGTACGCCGACTCCTTCACCTTTAACCCTTCCAAGTGGATGATGGTGCACTTTGACTGCACTGGGt TCTGGGTCAAGGACAAGTACAAGCTACAGCAGACCTTCAGTGTGAACCCCATC - -1080
GluTyrAlaAspSerPheThrPheAsnProSerLysTrpMetMetVa t Hi sPheAspCysThrG LyPheTrpValLysAspLysTyrLysLeuGlnGflnThrPheSerValAsnProI le- - 335
TACCTCAGACATGCGMACTCTGGTGTCGCCACTGACTTCATGCATTGGCAGATCCCCTTGAGCCGGCGCTTTCGCTCCAT TMGCTGTGGTTTGTGATTCGGTCCTTCGGGGTGAAGMAT --1200
TyrLeuArgHisAlaAsnSerGlyVaLAlaThrAspPheMetHisTrpGlnl leProLeuSerArgArgPheArgSerl LeLysLeuTrpPheVal IleArgSerPheGtyValLysAsn- - 375
CTTCAAGCACATGTCAGACACGGTACAGACATGGCTAAATACT TTGAATCTCTAGTCAGGAGCGACCCTGT T TTCGAAATTCCTGCTGAGAGGCACCTTGGTCTGGTGGTTTTTCGTCTG - -1320
LeuGlnAlaHisValArgHisGLyThrAspMetAlaLysTyrPheGLuSerLeuValArgSerAspProVa5PheGlul LeProAlaGluArgHisLeuGLyLeuVaLValPheArgLeu-- 415
AAGGGTCCCAACTGTCTCACAGAAA6tGTGTTAAAGGAAATAGCCAAAACT GGCCAGGTCTTCCTCATCCCAGCCACTATCCAGGACAAGCTGATCATCCGTTTCACCGT GACGTCCCAG --1440
LysGLyProAsnCysLeuThrGluSerVatLeuLysGLul leALaLysThrG yGlnValPheLeul leProAlaThrI eGtnAspLysLeul lel LeArgPheThrVatThrSerGln-- 455
_| DDC
TTCACCACCAAGGATGACATCCTGAGAGAT TGGMACCTCATCCGAGAGGCTGCTAACCTTGTCCTGAGCCAGCACTGCACT TCTCAGCCGAGCCCTCGGGCCMAGMCCTTATTCCACCG - -1560
PheThrThrLysAspAspl leLeuArgAspTrpAfsnLeul LeArgGLuAlaAlaAsnLeuValLeuSerG nH isCysThrSerGlnProSerProArgAlaLysAsnL~euI leProPro- - 495
CCGGTGACCAGAGACTCCAAAGACCTGACCAATGGGCTATCCCTGGAGTCTGTCAATGAGGGAGGAGATGACCCAGTACAGGTCCGGAAGATCTTCAGGCTGCCAGGAGACAGTCTGGAA- -1680
ProValThrArgAspSerLysAspLeuThrAsnGtyLeuSetLeuGLuSerValAsnGLuGLyGLyAspAspProValGlnValArgLysI tePheArgLeuProGlyAspSerLeuGlu-- 535
ACGACAATGGATCCCTT TGATGATTGCTTCTCAGAAGAGGCCTCCGATACCACCAAGCACAAGCTGTCGTCCTT TCTGTTCAGTTACTTGTCGGTACAGACAAGAAGAGACAATGCGG - -1800
ThrThrMetAspProPheAspAspCysPheSerGtuGluAlaSerAspThrThrLysHi sLysLeuSerSerPheLeuPheSerTyrLeuSerValGtlnsnLysLysLysThrMetArg- - 575
TCCCTCAGCTGCAACAGTATGCCTATGAGTGCCCAGAAGTCACCTCCCCCAGATGCTTCCGTGAAGCATGGGGGCTTCTTCCGGGCCAGAATCTTTTCTGGGTTCCCAGAAGAAATGATG- -1920
SerLeuSerCysAsnSerletProMetSerAtaGfnLysSerProProProAspAlaSerVa lLysH i sGtyGlyPhePheArgA laArgI lePheSerGlyPheProGtluGluMet~et- - 615
ATGATGGAAJAGGTGGCTTCMMAGCTGATCAAGTTCTACAGTGTTCCCAGCTTTCCTGMTGCAGCTCTCAGTGTGGTACCCTCCAGCTGCCCTGCTGCCCTCTGCAGGCCATGGTG--2040
MetMetLysLysGlyGtyPheLysLysLeul teLysPheTyrSerVatProSerPheProGluCysSerSerGlnCysGlyThrLeuGtlnLeuProCysCysProLeuGLtnAlMetVal - - 655
TAGGTGACGGGAGTCT TCAATCAGATGCAGGGTGTGCTTCAGGGAGTTCGGGAACCCTTGMATTGTGTGCAGTTTGTGTGCTTATTATGTATGTGTGTGCATCTTGAGGGAAGTAAG--2160
End
CCCATAAT TTTGATCATAGCCTCACAGGGGTTCATGACCCACATAGATTGGMTTGGGCAGTTTAAGCTGGCATGCT TCAGAGGGTTGCAGGGGCT TGTGTGACAGAGGGGCTGAGAG --2280
AGCAGTGTCCTGTTAAGCTTGTAATGTAAAAACAACCTAGAAATAAATTGTGCCTATATCTAAAAMAAA
FIG. 1. Nucleotide sequence and deduced amino acid sequence of clone HDC-18. The nucleotide and amino acid residue numbers are
indicated at the right. The region that is homologous with the gene for Drosophila DDC is indicated above the nucleotide sequence. A consensus
poly(A) addition signal (AATAAA) is underlined. The initial methionine is the first methionine residue following the putative transcription start
site in the gene (unpublished results). The arrowhead marks the first residue of clone HDC-21. Clone HDC-2.3 begins at residue 118. The letters
above the nucleotide sequence denote the differences in some HDC cDNA clones. Potential sites of N-glycosylation [Asn-Xaa-(Thr or Ser)]
are underlined. The site at residue 304 is adjacent to the putative PLP-binding site (Lys-307) and would likely inactivate the enzyme if
glycosylated. Two sequences fitting consensus phosphorylation sites of cAMP-dependent protein kinase (28) are located at residues 357-362
and 338-343. The nucleotide sequence was determined on both strands.
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and 151). Southern blotting and hybridization with nick-
translated [32P]DNA was performed as described by Wahl et
al. (19). Blot hybridization analysis of RNA was done as
described by Thomas (20) with [32P]DNA (21). For nucleotide
sequencing, restriction endonuclease fragments were sub-
cloned in bacteriophage M13 mpl8 or mpl9 (22). DNA
sequences were determined by the dideoxy method of Sanger
and coworkers (23, 24) with 35S-substituted deoxyadenosine
5'-[a-thioJtriphosphate (Amersham). Rat DNA was isolated
by the technique reported by Blin and Stafford (25). DNA and
protein sequences were analyzed with the MicroGenie com-
puter program (Beckman). Comparison of rat HDC and the
bacterial HDC proteins was done with the FASTA program of
Lipman and Pearson (26).
RESULTS
During studies of androgen-binding protein (ABP) gene
expression, a cDNA encoding ABP (27) and DDC-related
domains was isolated from a fetal rat liver cDNA library. The
cDNA consisted of 750 base pairs (bp) (5') ofABP cDNA and
2.3 kilobases (kb) (3') that shared 60% identity of nucleotide
residues with Drosophila cDNA encoding DDC. A 2.3-kb
EcoRI fragment (3') contained all of the DDC-related domain
and 17 bp ofABP cDNA, but this fragment did not hybridize
to ABP cDNA with our hybridization conditions. To identify
the nature of the DDC-related domain, a fetal rat liver cDNA
library (phage A gtll) was screened with the 2.3-kb DNA as
probe. Ten recombinants with inserts of 1.8-2.4 kb were
characterized by nucleotide sequence analysis. All of the
clones contained identical sequences with truncations at the
5'-end, the shorter clones apparently representing incom-
plete cDNA transcripts. Fig. 1 shows the nucleotide se-
quence and deduced amino acid sequence of the longest clone
(pCMVHDC-18). The DNA encodes a protein containing 655
amino acid residues ofMr 73,450. The sequence contains two
potential sites of N-glycosylation (residues 218 and 304) and
two sites that are homologous with the phosphorylation sites
of cAMP-dependent protein kinase (Fig. 1, residues flanking
Ser-342 and Ser-361). Nucleotide sequence analysis of the
cDNA isolates revealed that some of the HDC cDNA clones
contained three residues that were different from HDC-18.
These divergences are diagrammed in Fig, 1 (nucleotide
residues 98, 157, and 928). The alterations result in changes
in the encoded amino acid residues: His-8 -* Arg, Val-28 -*
Leu, and Arg-285 -* Cys respectively. This heterogeneity of
RNA transcripts may represent polymorphic genes in the
noninbred Sprague-Dawley rats. At least two alleles are
evident. Supporting this conclusion is the finding that all
HDC cDNA-hybridizing genomic restriction DNA fragments
(BamHI) map to rat chromosome 3 (D.R.J., P.M.S., and
Claude Szpirer, unpublished results). These data suggest a
single gene homologous with HDC cDNA; however, more
than one gene cannot be completely ruled out.
To identify the nature of the protein encoded by HDC
DNA, the cDNAs were cloned into the eukaryotic expression
vector pCMV5. Transfection ofmonkey kidney cells (COS-7)
with the recombinant plasmids (pCMVHDC) yielded HDC
activity in cell extracts, whereas the controls with an unre-
lated DNA insert (pCMVABP) or pCMV DNA with no insert
failed to produce detectable HDC activity (Table 1). Each of
the cDNAs tested (pCMVHDC-21 and pCMVHDC-18) rep-
resented one of the polymorphic transcripts; both yielded
HDC activity. Moreover, the COS cell extracts (pCMVHDC)
yielded no measurable DDC enzymatic activity. Thus, HDC
cDNA encodes a protein that can catalyze the conversion of
L-histidine to histamine but not L-dopa to dopamine.
Further evidence that the cDNA encodes HDC was ob-
tained by chromosomal linkage analysis. Southern blot anal-
ysis of 13 Chinese hamster-mouse hybrid cell DNAs showed
Table 1. Transient expression of HDC cDNA in monkey cells
HDC activity, units/







One unit ofHDC activity is defined by the formation of one pmol
of [3H]histamine per min at 370C. pCMVHDC-18 and pCMVHDC-21
are pCMV recombinants containing HDC cDNA (Fig. 1). pCMV5 is
the vector DNA without insert, and pCMVABP9 has an unrelated
insert, rat ABP cDNA (27). Transient expression of pCMVABP
DNA yields high-affinity androgen-binding activity, with character-
istics of native ABP.
that 7 contained the mouse HDC DNA fragments and that the
presence or absence of HDC-hybridizing DNA was corre-
lated with the presence or absence ofchromosome 2 (data not
shown). To localize HDC DNA within chromosome 2, we
analyzed an interspecific backcross. Southern blot analysis
of DNAs extracted from the progenitors of this backcross
showed that NFS/N mouse DNA yielded a 12-kb Xba
I-reactive fragment, whereas M. m. musculus DNA con-
tained a 15-kb fragment (Fig. 2). Analysis of 56 backcross
progeny showed that 31 animals inherited the NFS/
N-specific fragment. In the progeny, RFLPs of two chromo-
some 2 markers, Hc and Psp, could be detected after diges-
tion with the appropriate restriction enzymes. The data in
Table 2 confirm that HDC DNA is on mouse chromosome 2
and demonstrate that it lies in the middle of the chromosome
with the gene order Hc-HDC-Psp (Fig. 2). To confirm this
map location, 23 of these mice including the only double
recombinant were also typed for inheritance of a Sca I
polymorphism of the P2-microglobulin gene (B2m); no re-
combinants were detected. B2m and the HDC locus, Hdc, are
closely linked on chromosome 2 (Fig. 2). The genetic data
N
n2Et)









FIG. 2. (Left) Southern blot hybridization of DNA from M. m.
musculus, NFS/N mice, and backcrosses. Liver DNA from progen-
itor mice [NFS/N and M. m. musculus derived from wild mice (lane
WM)] and backcrosses was cleaved with Xba I and analyzed by
Southern blot hybridization. The segregation of the NFS/N-specific
band (12 kb in lane NFS) was determined in the backcrosses. Two
of the backcrosses, SK12 and SK13, were negative and positive,
respectively, for NFS/N mouse Hdc DNA. (Right) Diagram of
mouse chromosome 2, showing the location of the HDC locus (Hdc)
and the loci used as markers: Hc, B2m, and Psp. The arrow indicates
the mapped location of Hdc DNA, which corresponds to the Hdc
locus. Loci positions are from Davisson et al. (29). The Hdc locus
was mapped by Martin and Bulfield (30), using allelic variants with
heat-stability differences.
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HDC 15 - K E NV DY I C O Y L S T L R E R Q V T P N V K P G Y L R A 0 I P S SA P E E P
DDC 11 - K r M V D F I A E Y L E N I R E R R V L P E V K P C Y L K P L I P D A A P E K P HDC 252 -- V C A F D K L S E L G P I C A R E G L W L HV D A A Y A G r A F L C P E L R G F
* * * * *-- * * * * * * * - * DDC 248 - - S C A F D Y L D E C G P V G N K H N L W I H V D A A Y A G S A F I C P E Y R H L
HDC 55 D S W D S I F G D I E 0 1 I M P G V V N W Q S P HNM H A Y Y P A L T S W P S L L
DDC 51 E K W 0 D V M QD I E R V I M P G V T H W H S P K F H A Y F P T A N S Y P A rV
HDC 95 --G D M L AD AST A W G S R G LP A C T E L E N IM D W L A K M L G L PD
DDC 91 --A D ML S G IA C I G F T W IA S P A C T E L EV V MM D W L G K M L E L PA
HDC 134- F F L H H P SS G G G V L OR T V S E S T LISA L LL A R KN K I L EN KA
DDC 131 E F L A C S G GK G G G V I OG T A S E S T L VA S AGS 0 G E V E G GE
NDC 174 --HE P N A D E S S L N A R LV A Y A S D 0 AH S S VE K A G L I S L V K IK
DDC 169 -G A P S G V G L E HT I L G K LV G Y C S D 0 A HS S VE R A G L L G G V K LR
HDC 292 - L K G I E Y A D S F T F N P S K W MN V H F D C T G F W V K D K Y K L Q 0 T F S
DDC 28U -- K G I E S A D S F N F N P H K W N L V N F D C S A N W L K D P S W V V NA^ F N
HDC 332 --V N P I Y L R NA N S G V AT D F MH W IP L S R R F R S IK L W F V IR S F
DDC 328 -V D P L Y L K HD N QG S AP D Y RH W Q I P L G R R F R A LK L W F V LR L Y
HDC 372--G V K NL QA HV R H G TD A K YF E S L V R S D P V F E IP A E R H LG L V
DDC 368--G V E NL QA NI R R H C NF AK QF GD L C V A D S R F E L A E I N NG L V
HDC 412 V F R L K G P N C L T E S V L K E IA K T G Q V F L I PA T IO D K L I IR F T
DDC 408 S F R L K G S NE R NE A L L K R IN G R G N I N L V P A K IK D V Y G LRN A
HDC 212 --F L P V D D N F S L R G E A L 0 K A I E E D K Q G L V P V F V CA T L G T T G HDC 452 -V T S 0 F T T K D D I L R D W N L I R E A A
DDC 209 - S V S E N H R N R G A A L E K A I E Q D V A E G L I P F Y A V V T L G T T C 448- I C S R F TQS E D N E Y S W K E V S A AA
FIG. 3. Homology of deduced HDC amino acid sequence with Drosophila DDC. Amino acid residues are shown at the left of each line for
clone HDC-21 and DDC. The amino acid sequence of Drosophila DDC is that of Eveleth et al. (31) and Morgan et al. (32), with the presumed
initiating methionine codon as described (32). The PLP-binding site ofDDC is underlined. The remainder of the two sequences has no obvious
homology. The HDC amino acid sequence shared 50% identity of residues with rat DDC (33). The single-letter amino acid code is used.
presented here are consistent with the conclusion that the
HDC cDNAs represent HDC RNA transcripts. Since in both
genetic studies all of the mouse HDC restriction endonucle-
ase fragments segregated together, there is likely a single
mouse gene for HDC.
Comparison of the deduced amino acid sequence of rat
HDC with the National Biomedical Research Foundation
Protein Data Bank revealed extensive homology with the
amino acid sequence of DDC (EC 4.1.1.26). Fig. 3 compares
the deduced amino acid sequence of clone HDC-21 with
Drosophila DDC (31, 32). The homology begins at Lys-15 of
HDC-21 and Lys-11 of Drosophila DDC and ends near the C
terminus of DDC (residue 469) and residue 473 of HDC-21.
The amino acid sequence ofDDC at the pyridoxal phosphate
(PLP)-binding site (Lys-303) is highly homologous with the
HDC sequence (Fig. 3, underlined sequence; six of seven
residues identical). The C-terminal 182 residues of the HDC
amino acid sequence have no identity with DDC or any other
sequence in the data base. Likewise, the rat HDC amino acid
sequence shared -50% homology with rat DDC (Fig. 3
legend). The amino acid residues of rat HDC shared only 15%
overall identity with feline glutamic acid decarboxylase (34);
only 90 residues around the PLP-binding site showed signif-
icant similarity (50%). No obvious homology was observed
between rat HDC and murine ornithine decarboxylase (35) or
bacterial (Lactobacillus) pyruvyl-containing HDC (36, 37).
However, a limited but apparently significant similarity was
observed between the rat HDC sequence and the PLP-
Table 2. Segregation of HDC-hybridizing restriction fragments
with those of Hc and Psp among 56 progeny of the backcross:
(NFS/N x M. m. musculus) F1 x M. m. musculus
Inheritance of NFS
mouse RFLP* Mice,
Progeny Hc HDC Psp no.
Parental + + + 16
- - - 11
Single recombinants + + - 7
_ _ + 4
+ - - 8
_ + + 9
Double recombinants - + - 1
*Recombination (r) values are: for Hc-HDC, r = 18 of 56 = 32 ±
6.2%; for HDC-Psp, r = 12 of 56 = 21 ± 5.4%; and for Hc-Psp, r
= 28 of 56 (not significant).
dependent bacterial HDC from Morganella morganii (38).
Residues 217-374 of rat HDC and residues 122-278 of Mor-
ganella HDC shared 39 identical residues. These regions
flank the PLP-binding site (lysine) in Morganella HDC and
the potential PLP-binding site in rat HDC.
DISCUSSION
We have cloned the cDNA encoding fetal rat liver HDC, and
the full amino acid sequence was deduced from the nucleo-
tide sequence. Although no amino acid sequence for eukary-
otic HDC was available for comparison, the nature of the
cloned cDNAs was proven by expression of the cDNA in
COS cells to yield HDC enzymatic activity and demonstra-
tion that the cDNA sequence was linked to the Hdc locus.
The amino acid sequence of the amino-terminal 462 residues
of rat HDC was highly homologous with rat DDC and
Drosophila DDC. This homology included the region around
the PLP-binding site of Drosophila DDC. The major differ-
ence was the presence of a serine residue adjacent to the rat
HDC PLP-binding lysine in place of the histidine in Droso-
phila DDC (31, 32). This histidine residue is conserved in
feline glutamic acid decarboxylase (34) and ornithine de-
carboxylase (35) and in the bacterial (E. colt) arginine, lysine,
ornithine, histidine, and glutamic acid decarboxylases (39). A
serine residue adjacent to the PLP-binding lysine has been
described in eukaryotic aspartate and alanine aminotrans-
ferases and E. coli D-serine dehydratase (39). The signifi-
cance of histidine or serine in this position is not known. The
close sequence homology of HDC with DDC is consistent
with the known immunological properties of antibodies
against rat HDC. Taguchi et al. (8) found that rabbit anti-rat
HDC crossreacts with guinea pig DDC and HDC but not with
rat DDC.
Characterization of the purified rat HDC from fetal liver
revealed that, like eukaryotic DDC, the enzyme consists of
two Mr 55,000 subunits, which are likely identical -(7). How-
ever, the cDNA clones we isolated from fetal liver encode a
protein of Mr 73,000. This difference in size suggests that the
HDC primary translation product may be posttranslationally
processed. Perhaps the carboxyl-terminal 180 residues, which
are not homologous to DDC, are cleaved to form the catalyt-
ically active HDC. Although no PLP-dependent decarboxyl-
ases are known to undergo posttranslational proteolysis, an-
other class of bacterial HDC, the pyruvyl-containing HDC,
undergoes autocatalytic modification and cleavage at a spe-
736 Neurobiology: Joseph et al.
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cific Ser-Ser bond (40). Alternatively, the differences in size
between the native and deduced recombinant protein could be
explained if the denatured protein migrates aberrantly during
gel electrophoresis. However, the size of the native protein
(Mr 110,000) does not support this explanation.
Many studies have suggested that isozymes of HDC exist
in mammals. For example, Savany and Cronenberger (5)
described three isozymes in rat gastric mucosa with pI values
of 5.35, 5.65, and 5.90, whereas Watanabe et al. (41) identi-
fied two types of HDC in fetal and cerebral tissues, with pI
values of 5.0 and 5.4, respectively. Others have found that a
fraction of rat brain HDC is membrane bound (42). Our
studies suggest several possible explanations for the ob-
served heterogeneity of HDC. First, the different forms of
cloned rat HDC (possibly allelic variants) could each have
different pl values. Second, the presence of two potential
N-glycosylation sites in the HDC sequence raises the possi-
bility that the protein is glycosylated. Glycosylated proteins
generally exhibit charge heterogeneity because of differences
in the carbohydrate content. The characteristics of the native
cytoplasmic protein indicate that most HDC is not glycosy-
lated; however, a membrane-bound fraction could be glyco-
sylated. Third, sequence analysis of HDC also revealed two
potential sites of phosphorylation that closely fit the consen-
sus recognition sequence of cAMP-dependent protein kinase
(28). This finding supports the in vitro studies, suggesting that
phosphorylation of brain HDC by cAMP-dependent protein
kinase leads to enzyme inactivation (43). Also, each of the
two HDC mRNA species (major 2.7 kb and minor 3.5 kb) as
revealed by Northern hybridization analysis (unpublished
results) could encode unique proteins (i.e., alternative splic-
ing of RNA transcripts).
The physiological importance of HDC in gastric acid
secretion, respiratory pathway constriction, vasomotor con-
trol, and neurotransmission is well documented (1-3). With
the cloning of HDC cDNA and knowledge of the amino acid
sequence, the tools are now available to study the mechanism
that regulates histamine biosynthesis at the molecular level.
Preliminary studies in our laboratory have identified the
putative regulatory promoter region of the rat Hdc gene.
Future studies on Hdc gene regulation can be related to the
physiological functions of HDC and histamine.
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